ZAP Surgical Celebrates 5,000th Patient Treated Globally with ZAP-X® Gyroscopic Radiosurgery® Platform

Audio By Carbonatix

SAN CARLOS, Calif.--(BUSINESS WIRE)--Aug 12, 2025--

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the treatment of the 5,000th patient using its ZAP-X ® Gyroscopic Radiosurgery ® platform — a major milestone reflecting the platform’s rapid worldwide adoption.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812189929/en/

Christopher Czerwinski celebrates completion of his treatment with the ZAP-X® Gyroscopic Radiosurgery® platform at Jersey Shore University Medical Center.

The case was performed at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center in Neptune, New Jersey. The patient, Christopher Czerwinski, a 64-year-old Trauma & ICU Nurse, was treated for a right-sided cavernous sinus meningioma. Mr. Czerwinski first noticed diplopia (double vision) nearly two years ago, with symptoms peaking in April 2025 while on vacation at Disney World with his wife — where he humorously recalls seeing two Cinderella castles. An ophthalmologist subsequently referred him for further testing, which led to an MRI and diagnosis. His condition was originally managed with prism glasses and contact lenses.

Mr. Czerwinski ultimately selected Jersey Shore University Medical Center for his radiosurgical care due to the capabilities of the ZAP-X platform and the proven expertise of the medical team. Mr. Czerwinski underwent ZAP-X treatment and tolerated the procedure exceptionally well, resuming his active lifestyle immediately thereafter.

“Stereotactic radiosurgery continues to redefine how we manage challenging cranial conditions,” said Shabbar F. Danish, M.D., FAANS, chair of Neurosurgery, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center and professor of Neurosurgery, Hackensack Meridian School of Medicine. “With the precision and versatility of ZAP-X, we were able to deliver focused treatment while minimizing exposure to surrounding critical structures. Mr. Czerwinski’s case is a prime example of how we can address complex tumors while preserving quality of life.”

An avid runner and budding pianist, Mr. Czerwinski also enjoys photography, working out with his wife, and spending time with friends and family. As a healthcare provider himself, he expressed deep appreciation for the compassionate care he received and the non-invasive nature of the ZAP-X procedure.

“I’m pleased our clinical experts have enabled the communities we serve to receive this advanced procedure at our academic medical center, without the need to travel far from home,” said Vito Buccellato, MPA, LNHA, president and chief hospital executive of Jersey Shore University Medical Center.

The ZAP-X platform represents a new frontier in cranial radiosurgery. By employing gyroscopic beam delivery, ZAP-X can direct radiation from thousands of angles to concentrate dose on the tumor while sparing healthy brain tissue and helping protect nearby organs at risk, such as the optic nerves and brainstem. The procedure is painless, incisionless, and often completed in a single outpatient session — without the need for anesthesia or hospital admission.

“The treatment of our 5,000th patient not only represents a numerical milestone, but a reaffirmation of our mission to make brain radiosurgery safer, smarter, and more accessible,” said John R. Adler, M.D., founder and CEO of ZAP Surgical, and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University.

ZAP-X is the first and only dedicated cranial SRS platform that does not require radioactive Cobalt-60. Instead, it uses a modern linear accelerator to generate radiation, eliminating the safety, storage, and regulatory challenges associated with isotope-based systems. Furthermore, ZAP-X is the only vault-free solution in its category, thereby allowing installation in clinical settings with interior and exterior facing windows.

“We recruited experts in their fields, Dr. Shabbar Danish and Dr. Timothy Chen, in part so that we could add to the available, leading-edge treatment technologies at Jersey Shore and HMH,” said Kenneth N. Sable, M.D., MBA, FACEP, president, Acute Hospital Division, Hackensack Meridian Health. “I’m thrilled that the 5,000th patient to receive ZAP-X treatment is from our local community.”

For information about Jersey Shore University Medical Center’s ZAP-X program, visit www.hackensackmeridianhealth.org/en/services/neurosciences/gyroscopic-radiosurgery-integrated-with-magnetic-resonance-imaging.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X ® Gyroscopic Radiosurgery ® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife ® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at www.zapsurgical.com and follow us on LinkedIn.

ABOUT HACKENSACK MERIDIAN HEALTH

Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey’s largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy.

Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey’s #1 children’s hospital and the state’s only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit www.hackensackmeridianhealth.org.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250812189929/en/

CONTACT: Mark Arnold, ZAP Surgical Systems, Inc.

Senior Vice President, Marketing

+1 650 492 7797, ext. 101

KEYWORD: CALIFORNIA NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY BIOTECHNOLOGY RADIOLOGY HEALTH GENERAL HEALTH ONCOLOGY

SOURCE: ZAP Surgical Systems, Inc.

Copyright Business Wire 2025.

PUB: 08/12/2025 07:15 AM/DISC: 08/12/2025 07:17 AM

http://www.businesswire.com/news/home/20250812189929/en